Publication:

Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data (2009)

Author(s): Klein TE, Altman RB, Eriksson N, Gage BF, Kimmel SE, Lee MTM, Limdi NA, Page D, Roden DM, Wagner MJ, Caldwell MD, Johnson JA, Chen YT, Wen MS, Caraco Y, Achache I, Blotnick S, Muszkat M, Shin JG, Kim HS, Suarez-Kurtz G, Perini JA, Silva-Assuncao E, Anderson JL, Horne BD, Carlquist JF, Caldwell MD, Berg RL, Burmester JK, Goh BC, Lee SC, Kamali F, Sconce E, Daly AK, Wu AHB, Langaee TY, Feng H, Cavallari L, Momary K, Pirmohamed M, Jorgensen A, Toh CH, Williamson P, McLeod H, Evans JP, Weck KE, Brensinger C, Nakamura Y, Mushiroda T, Veenstra D, Meckley L, Rieder MJ, Rettie AE, Wadelius M, Melhus H, Stein CM, Schwartz U, Kurnik D, Deych E, Lenzini P, Eby C, Chen LY, Deloukas P, Motsinger-Reif A, Sagreiya H, Srinivasan BS, Lantz E, Chang T, Ritchie M, Lu LS, Shin JG, International Warfarin Pharmacogenetics Consortium

      • Date: 01-02-2009
      • Journal: New England Journal of Medicine
      • Volume: 360
      • Issue: 8
      • Pages: 753-764
      • Publisher: Massachusetts Medical Society
      • Publication type: Article
      • Bibliographic status: Published

      Keywords: K EPOXIDE REDUCTASE GAMMA-GLUTAMYL CARBOXYLASE AFRICAN-AMERICANS CYTOCHROME P4502C9 COAGULATION-FACTOR PRIME-TIME VKORC1 POLYMORPHISMS REQUIREMENTS RESISTANCE

      Staff

      Professor Ann Daly
      Professor of Pharmacogenetics